“…IL-l-induced CRH release is well documented [3,5,38,42,43] and GH secretion is inhibited by CRH [30,36,37], CRH stimulates the re lease of somatostatin [1,26,34], the hypothalamic neurocrine inhibiting pituitary GH secretion. Somatostatin also inhibits GHRH release [21,25], and antiserum to so matostatin blocks CRH- [20,37] or stress-induced [2,41] suppression of GH secretion. It is suggested, therefore, that with high doses of IL-1, somatostatin secretion is stimulated through IL-l-induced increased release of CRH; somatostatin, in turn, inhibits GHRH release and ultimately suppresses pituitary GH secretion.…”